Your browser does not support JavaScript! STRONGID T (PYRANTEL PAMOATE) SUSPENSION [PFIZER ANIMAL HEALTH]

Veterinary Medicine Labels  

                Current Medication Information

Options

RxNorm Names

STRONGID T (pyrantel pamoate) suspension
[Pfizer Animal Health]


Category DEA Schedule Marketing Status
PRESCRIPTION ANIMAL DRUG LABEL New Animal Drug Application
Drug Label Sections

Equine Anthelmintic Suspension

CAUTION

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION

Strongid T is a suspension of pyrantel pamoate in a palatable caramel-flavored vehicle. Each mL contains 50 mg of pyrantel base as pyrantel pamoate.

Pyrantel pamoate is a compound belonging to a family classified chemically as tetrahydropyrimidines. It is a yellow, water-insoluble crystalline salt of the tetrahydropyrimidine base and pamoic acid containing 34.7% base activity. The chemical structure and name are given below:

Chemical Structure

(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl) vinyl] pyrimidine 4,4' methylenebis[3-hydroxy-2-naphthoate] (1:1)

INDICATIONS AND USAGE

For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); pinworms (Oxyuris equi); large roundworms (Parascaris equorum); and small strongyles in horses and ponies.

CONTRAINDICATIONS

It is recommended that severely debilitated animals not be treated with this preparation.

WARNINGS

Do not use in horses intended for human consumption. Keep out of reach of children.

PRECAUTION

This product is a suspension and as such will separate. To insure uniform resuspension and to achieve proper dosage, it is extremely important that the product be shaken and stirred thoroughly before every use.

DOSAGE AND ADMINISTRATION

Administer 3 mg pyrantel base per lb of body weight (6 mL Strongid T per 100 lb of body weight). For maximum control of parasitism, it is recommended that foals (2–8 months of age) be dosed every 4 weeks. To minimize potential hazard that the mare may pose to the foal, she should be treated 1 month prior to anticipated foaling date followed by retreatment 10 days to 2 weeks after birth of foal. Horses over 8 months of age should be routinely dosed every 6 weeks.

Directions for use

Strongid T may be administered by means of a stomach tube, dose syringe or by mixing into the feed.

Stomach Tube

Measure the appropriate dosage of Strongid T and mix in the desired quantity of water. Protect drench from direct sunlight and administer to the animal immediately following mixing. Do not attempt to store diluted suspension.

Strongid T is inactive against the common horse bot (Gasterophilus spp.) However, Strongid T may be administered concurrently with carbon disulfide observing the usual precautions with carbon disulfide.

Dose Syringe

Draw the appropriate dosage of Strongid T into a dose syringe and administer to the animal. Do not expose Strongid T to direct sunlight.

Feed

Mix the appropriate dosage of Strongid T in the normal grain ration. Fasting of animals prior to or following treatment is not required.

EFFICACY

Critical (worm-count) studies in horses demonstrated that Strongid T administered at the recommended dosage was efficacious against mature infections of Strongylus vulgaris (>90%), S. edentatus (69%), S. equinus (>90%), Oxyuris equi (81%), Parascaris equorum (>90%), and small strongyles (90%).

SAFETY

Strongid T is well tolerated by horses and ponies of all ages. No adverse drug response was observed when dose rates up to 60 mg of pyrantel base per lb of body weight were administered by stomach tube nor when 3 mg base per lb was given by intratracheal injection. The reproductive performance of pregnant mares and stud horses dosed with Strongid T has not been affected.

RECOMMENDED STORAGE

Store below 30°C (86°F).

HOW SUPPLIED

Strongid T is supplied in 1 quart (946 mL) bottles.

NADA #91-739, Approved by FDA

TAKE TIME OBSERVE LABEL DIRECTIONS

Distributed by:
Pfizer Animal Health
Div. of Pfizer Inc
NY, NY 10017

10232100
81463930
Printed in USA

PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label

Strongid® T
(pyrantel pamoate)

Equine
Anthelmintic
Suspension

Active Ingredient: 50 mg of pyrantel
base as pyrantel pamoate per mL

Caution: Federal law restricts this
drug to use by or on the order of
a licensed veterinarian.

Net Contents: 1 quart (946 mL)

NADA #91-739, Approved by FDA

Pfizer

PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label
STRONGID T 
pyrantel pamoate suspension
Product Information
Product TypePRESCRIPTION ANIMAL DRUG LABELItem Code (Source)NDC:61106-2384
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
pyrantel pamoate (pyrantel) pyrantel50 mg  in 1 mL
Product Characteristics
Color    Score    
ShapeSize
FlavorCARAMELImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:61106-2384-1946 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NADANADA09173910/19/1973
Labeler - Pfizer Animal Health (039055157)
Establishment
NameAddressID/FEIBusiness Operations
Pfizer Animal Health039055157MANUFACTURE

Revised: 8/2010
 
Pfizer Animal Health

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services